Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynda S Welage

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Gastroenterology Clinics of North America|October 15, 2003
Pharmacologic features of proton pump inhibitors and their potential relevance to clinical practiceLynda S Welage
Pharmacotherapy|November 1, 2003
Pharmacologic properties of proton pump inhibitorsLynda S Welage
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2005
Overview of pharmacologic agents for acid suppression in critically ill patientsLynda S Welage
Pharmacotherapy|December 21, 2002
Strategies to optimize drotrecogin alfa (activated) use: guidelines and therapeutic controversiesHenry Cohen, Lynda S Welage
Critical Care Medicine|June 10, 2004
The cost-effectiveness of proton pump inhibitors for bleeding peptic ulcers: The unanswered questionsJohn W Devlin, Lynda S Welage
Archives of Internal Medicine|October 13, 2010
High-dose PPIs in patients with variceal hemorrhageCesar Alaniz, Rima A Mohammad, Lynda S Welage
Pharmacotherapy|March 3, 2009
Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhageCesar Alaniz, Rima A Mohammad, Lynda S Welage
The Annals of Pharmacotherapy|October 6, 2005
Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economicsJohn W Devlin, Lynda S Welage, Keith M Olsen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 2009
Effect of a Web-based continuing-education program on pharmacist learningBurgunda V Sweet, Lynda S Welage, John P Johnston
The Annals of Pharmacotherapy|August 25, 2005
Proton pump inhibitor formulary considerations in the acutely ill. Part 1: Pharmacology, pharmacodynamics, and available formulationsJohn W Devlin, Lynda S Welage, Keith M Olsen
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Gastroenterology Clinics of North America|October 15, 2003
Pharmacologic features of proton pump inhibitors and their potential relevance to clinical practiceLynda S Welage
Pharmacotherapy|November 1, 2003
Pharmacologic properties of proton pump inhibitorsLynda S Welage
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2005
Overview of pharmacologic agents for acid suppression in critically ill patientsLynda S Welage
Pharmacotherapy|December 21, 2002
Strategies to optimize drotrecogin alfa (activated) use: guidelines and therapeutic controversiesHenry Cohen, Lynda S Welage
Critical Care Medicine|June 10, 2004
The cost-effectiveness of proton pump inhibitors for bleeding peptic ulcers: The unanswered questionsJohn W Devlin, Lynda S Welage
Archives of Internal Medicine|October 13, 2010
High-dose PPIs in patients with variceal hemorrhageCesar Alaniz, Rima A Mohammad, Lynda S Welage
Pharmacotherapy|March 3, 2009
Continuous infusion of pantoprazole with octreotide does not improve management of variceal hemorrhageCesar Alaniz, Rima A Mohammad, Lynda S Welage
The Annals of Pharmacotherapy|October 6, 2005
Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economicsJohn W Devlin, Lynda S Welage, Keith M Olsen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 2009
Effect of a Web-based continuing-education program on pharmacist learningBurgunda V Sweet, Lynda S Welage, John P Johnston
The Annals of Pharmacotherapy|August 25, 2005
Proton pump inhibitor formulary considerations in the acutely ill. Part 1: Pharmacology, pharmacodynamics, and available formulationsJohn W Devlin, Lynda S Welage, Keith M Olsen
Pageof 4